drugset / Trial / NCT02127021
The Effects of High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy
RandomizedParallel-groupDouble-blindSupportive care
Summary
Up to now, the studies concerning nutritional assessment after pancreatic resection were rare. The low-dose pancreatic enzyme treatment after pancreatectomy showed no significant benefit in terms of nutritional status. This study is a multicenter randomized phase IV study by using high-dose Norzyme® (40,000 IU) to evaluate quality of life and nutritional status after pancreaticoduodenectomy.
Timeline
- Start
- 2014-04
- Primary completion
- 2017-09-07
- Completion
- 2017-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pancrelipase | Protein / enzyme biologic | 40000 iu | Oral |